CN102366602A - Traditional Chinese medicine formula used for treating rheumatism - Google Patents
Traditional Chinese medicine formula used for treating rheumatism Download PDFInfo
- Publication number
- CN102366602A CN102366602A CN2011103211871A CN201110321187A CN102366602A CN 102366602 A CN102366602 A CN 102366602A CN 2011103211871 A CN2011103211871 A CN 2011103211871A CN 201110321187 A CN201110321187 A CN 201110321187A CN 102366602 A CN102366602 A CN 102366602A
- Authority
- CN
- China
- Prior art keywords
- radix
- rhizoma
- chinese medicine
- formula
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 claims description 17
- 238000002360 preparation method Methods 0.000 claims description 5
- 241000271039 Agkistrodon Species 0.000 claims description 3
- 241000756943 Codonopsis Species 0.000 claims description 3
- 241000628997 Flos Species 0.000 claims description 3
- 241000237903 Hirudo Species 0.000 claims description 3
- 239000009636 Huang Qi Substances 0.000 claims description 3
- 241001057584 Myrrha Species 0.000 claims description 3
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 3
- 241000180649 Panax notoginseng Species 0.000 claims description 3
- 241000237636 Pheretima Species 0.000 claims description 3
- 241000131808 Scolopendra Species 0.000 claims description 3
- 241000522620 Scorpio Species 0.000 claims description 3
- 239000010135 fructus aurantii immaturus Substances 0.000 claims description 3
- 239000009286 sanguis draxonis Substances 0.000 claims description 3
- 239000009490 scorpio Substances 0.000 claims description 3
- 210000000582 semen Anatomy 0.000 claims description 3
- 201000010099 disease Diseases 0.000 description 17
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 17
- 230000007812 deficiency Effects 0.000 description 12
- 208000006820 Arthralgia Diseases 0.000 description 10
- 208000002193 Pain Diseases 0.000 description 9
- 239000008280 blood Substances 0.000 description 9
- 210000004369 blood Anatomy 0.000 description 7
- 238000000034 method Methods 0.000 description 6
- 210000003205 muscle Anatomy 0.000 description 6
- 230000017531 blood circulation Effects 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 230000001105 regulatory effect Effects 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 230000008569 process Effects 0.000 description 4
- 208000032023 Signs and Symptoms Diseases 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 230000004069 differentiation Effects 0.000 description 3
- 235000008216 herbs Nutrition 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 230000008506 pathogenesis Effects 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 238000010792 warming Methods 0.000 description 3
- 208000031975 Yang Deficiency Diseases 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 230000001617 migratory effect Effects 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 230000001047 pyretic effect Effects 0.000 description 2
- 206010039073 rheumatoid arthritis Diseases 0.000 description 2
- 210000004872 soft tissue Anatomy 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 206010002556 Ankylosing Spondylitis Diseases 0.000 description 1
- 208000036487 Arthropathies Diseases 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 241000905957 Channa melasoma Species 0.000 description 1
- 208000000094 Chronic Pain Diseases 0.000 description 1
- 208000004044 Hypesthesia Diseases 0.000 description 1
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
- 208000012659 Joint disease Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- CMWTZPSULFXXJA-UHFFFAOYSA-N Naproxen Natural products C1=C(C(C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-UHFFFAOYSA-N 0.000 description 1
- 239000009798 Shen-Fu Substances 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000001760 anti-analgesic effect Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 230000001363 autoimmune Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000011443 conventional therapy Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000009688 danggui sini Substances 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 229960001259 diclofenac Drugs 0.000 description 1
- DCOPUUMXTXDBNB-UHFFFAOYSA-N diclofenac Chemical compound OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl DCOPUUMXTXDBNB-UHFFFAOYSA-N 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 210000003195 fascia Anatomy 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 208000034783 hypoesthesia Diseases 0.000 description 1
- 229960001680 ibuprofen Drugs 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 229960003444 immunosuppressant agent Drugs 0.000 description 1
- 230000001861 immunosuppressant effect Effects 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 229960000905 indomethacin Drugs 0.000 description 1
- 239000008929 jingui shenqi Substances 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 210000000865 mononuclear phagocyte system Anatomy 0.000 description 1
- 229960002009 naproxen Drugs 0.000 description 1
- CMWTZPSULFXXJA-VIFPVBQESA-N naproxen Chemical compound C1=C([C@H](C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-VIFPVBQESA-N 0.000 description 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 238000000554 physical therapy Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 210000001171 synovial bursa Anatomy 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 239000008445 zuogui Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese medicine formula used for treating rheumatism. The formula comprises more than ten Chinese herbal medicines such as divaricate saposhnikovia, incised notopterygium rhizome and root, angelica archang lica, manchurian wildginger herb, lobed kudzuvine root, black cicada slough, mint, and doubleteeth angelica root. When the formula provided by the invention is used in treatment, human body immunity functions can be regulated, pathogenetic conditions can be effectively released, body constitutions can be improved, reoccurrence risks during a hormone withdrawing process can be reduced, and occurrence frequency and occurrence severity can be reduced. Therefore, with the formula, disease processes can be effectively retarded or even blocked.
Description
Technical field
The invention belongs to field of medicaments, the rheumatismal Chinese medicine preparation of particularly a kind of treatment.
Background technology
Rheumatism is the abbreviation of rheumatism in the medical concept in modern times; Rheumatism is at the chronic pain that medically is articulations digitorum manus and surrounding soft tissue's unknown cause thereof; Rheumatism refer to then that one big type of cause of disease has nothing in common with each other but common ground for involving joint and surrounding soft tissue, comprise the disease of flesh, ligament, synovial bursa, fascia.Arthropathy has pain outward still with swelling and moving obstacle, is outbreak and alleviates the alternative chronic course of disease.Because patient's blood circulation is obstructed; Cause muscle or organize needed nutrition to carry through blood circulation; Cause patient's muscle to lack nutrition and accelerated ageing becomes stiff; Serious meeting causes patient's muscle and blood vessel atrophy, part patient and the joint can occur and disable depleted with viscera function.Because involving the joint mostly, rheumatism causes pain, so rheumatism one speech is used till today always.Rheumatism is relevant with autoimmune because of it, and the touching difficulty of numerous diseases heals, and the patient who has needs lifelong medication treatment.Still do not have at present the medicine of this type of disease of radical cure, western medical treatment is mainly non-steroidal anti-inflammatory drug, immunosuppressant and hormone, and the side effect of its long-term prescription is the same with its therapeutical effect should be not out in the cold.Therefore Chinese medicine demonstrates its special advantages day by day in rheumatismal treatment, is containing potentiality greatly.
Summary of the invention
The technical problem that the present invention will solve is to rheumatismal cause of disease characteristics, works out a kind ofly can effectively treat rheumatismal Chinese medicine preparation.
The rheumatismal Chinese medicine preparation of a kind of treatment, the component of this prescription is:
Windproof 25～30g; Rhizoma Et Radix Notopterygii 25～30g; The Radix Angelicae Dahuricae 12～15g; Herba Asari 8～10g; Radix Puerariae 20～30g; Periostracum Cicadae 12～15g; Herba Menthae 10～15g; Radix Angelicae Pubescentis 20～30g; Radix Aconiti Preparata 8～10g; 1～2 of Agkistrodon; Lignum Pini Nodi 15～20g; Ramulus Mori 15～20g; Rhizoma Dioscoreae Nipponicae 10～15g; Rhizoma Cibotii 15～20g; Rhizoma Homalomenae 15～20g; Cortex Magnoliae Officinalis 15～20g; Fructus Amomi 8～10g; Fructus Aurantii Immaturus 15～20g; The Radix Linderae 15～20g; Pericarpium Citri Reticulatae 20～30g; Radix Cirsii Japonici 15～20g; Radix Notoginseng 15～20g; Myrrha 15～20g; Radix Curcumae 15～20g; Oletum Trogopterori 10～15g; Flos Carthami 20～30g; Semen Persicae 20～30g; Radix Salviae Miltiorrhizae 25～30g; Rhizoma Drynariae 15～20g; Sanguis Draxonis 15～20g; Hirudo 10～15g; Ramulus Uncariae Cum Uncis 15～20g; Rhizoma Gastrodiae 15～20g; Pheretima 10～15g; Scorpio 10～15g; 2～3 of Scolopendras; The bar Radix Astragali 15～20g; Radix Codonopsis 10～15g; Rhizoma Curculiginis 12～15g; The Cortex Eucommiae 15～20g; Radix Angelicae Sinensis 20～30g; Radix Rehmanniae Preparata 15～20g; Radix Glycyrrhizae 15～20g; Radix Asparagi 15～20g; Rhizoma Polygonati Odorati 15～20g; Fructus Ligustri Lucidi 10～15g; Herba Ecliptae 15～20g.
Use prescription according to the invention to treat, can be through regulating the immunologic function of human body, mitigate the disease effectively; Improve body constitution; Reduce hormone and remove the danger that recurs in the process of subtracting, reduce the attack times and the outbreak order of severity, thereby can slow down even stop the process of disease effectively.
Specific embodiments
Rheumatismal Therapeutic Method mainly is divided into: western medical treatment, Chinese traditional treatment or operative treatment.
Western medical treatment mainly adopts non-black body anti-inflammatory agent, and this type of medicine has better effects to removing pain, but can not change the course of disease of disease because of suppressing the anti-inflammatory analgesic effect that produces rapidly of synthesizing of prostaglandin.Commonly used clinically have ibuprofen, naproxen, diclofenac, aspirin, an indomethacin etc.
Operative treatment comprises displacement, synovectomy of different orthomorphias, artificial joint etc.Operation can not cure diseases can only improve the ability of function of joint and life.
Physiotherapy can promote QI-blood circulation, relaxing muscles and tendons and activating QI and blood in the collateral, ease the pain, and is a kind of good auxiliary treating method.
The treatment by Chinese herbs rheumatism maximum characteristics are determination of treatment based on pathogenesis obtained through differentiation of symptoms and signs, integrally-regulated.For the rheumatisant, the main clinical manifestation current according to patient at first distinguished its characteristic of disease, is the deficiency and excess cold and heat, like true card, is migratory arthralgia, arthralgia due to cold, pyretic arthralgia or arthralgia chiefly caused by damp pathogen when distinguishing.The present invention treats rheumatismal experience for many years through the inventor, develops the rheumatismal prescription of a kind of effective treatment, and the concrete component of this prescription is following:
Windproof 25～30g; Rhizoma Et Radix Notopterygii 25～30g; The Radix Angelicae Dahuricae 12～15g; Herba Asari 8～10g; Radix Puerariae 20～30g; Periostracum Cicadae 12～15g; Herba Menthae 10～15g; Radix Angelicae Pubescentis 20～30g; Radix Aconiti Preparata 8～10g; 1～2 of Agkistrodon; Lignum Pini Nodi 15～20g; Ramulus Mori 15～20g; Rhizoma Dioscoreae Nipponicae 10～15g; Rhizoma Cibotii 15～20g; Rhizoma Homalomenae 15～20g; Cortex Magnoliae Officinalis 15～20g; Fructus Amomi 8～10g; Fructus Aurantii Immaturus 15～20g; The Radix Linderae 15～20g; Pericarpium Citri Reticulatae 20～30g; Radix Cirsii Japonici 15～20g; Radix Notoginseng 15～20g; Myrrha 15～20g; Radix Curcumae 15～20g; Oletum Trogopterori 10～15g; Flos Carthami 20～30g; Semen Persicae 20～30g; Radix Salviae Miltiorrhizae 25～30g; Rhizoma Drynariae 15～20g; Sanguis Draxonis 15～20g; Hirudo 10～15g; Ramulus Uncariae Cum Uncis 15～20g; Rhizoma Gastrodiae 15～20g; Pheretima 10～15g; Scorpio 10～15g; 2～3 of Scolopendras; The bar Radix Astragali 15～20g; Radix Codonopsis 10～15g; Rhizoma Curculiginis 12～15g; The Cortex Eucommiae 15～20g; Radix Angelicae Sinensis 20～30g; Radix Rehmanniae Preparata 15～20g; Radix Glycyrrhizae 15～20g; Radix Asparagi 15～20g; Rhizoma Polygonati Odorati 15～20g; Fructus Ligustri Lucidi 10～15g; Herba Ecliptae 15～20g.
Above-mentioned prescription is mainly treated: rheumatic arthritis, soreness of waist and ache in legs, cervical vertebra, lumbar vertebra, kidney-replenishing, and bone and muscle strengthening, wind-damp dispelling, benefiting essence-blood can steep medicated wine, also can process capsule, granule or oral liquid etc.
The characteristics of treatment by Chinese herbs disease:
1. determination of treatment based on pathogenesis obtained through differentiation of symptoms and signs is integrally-regulated
The Chinese traditional treatment disease maximum characteristics are determination of treatment based on pathogenesis obtained through differentiation of symptoms and signs, integrally-regulated.For the rheumatisant, the main clinical manifestation current according to patient at first distinguished its characteristic of disease; Be the deficiency and excess cold and heat; Be like true card, migratory arthralgia, arthralgia due to cold, pyretic arthralgia or arthralgia chiefly caused by damp pathogen when distinguishing? Empty partially like body constitution, when judgement is the deficiency of vital energy, blood deficiency, the deficiency of YIN, yang deficiency, caused by liver and kidney deficiency; Or deficiency of spleen and stomach? Then comprehensively dialectical, integrally-regulated.As wind-cold damp pathogen retardance meridians joint arranged outward, in deficiency of qi and blood is arranged, deficiency of the liver and kindey sees that chills and pain of the waist and kness, articular muscle are weighing diseases such as numbness, the sufficient joint stuffiness of lower limb, treats with the Radix Angelicae Pubescentis et Herba Taxilli Decoction plus-minus; Deficiency of qi and blood, the cold passages through which vital energy circulates that stagnates see that extremities joint cold type of pain, lustreless complexion person are with the treatment of danggui sini decoction plus-minus; The deficiency of YIN is pressed from both sides damp and hot person, closes Simiao San with Zuogui Yin; Yang deficiency folder cold-damp person adds flavor or the like with JINGUI SHENQI WAN.
2. the rapid mitigation symptoms of ability effectively slows down disease process
Many patient's commitments possibly be confined to several symptoms such as arthralgia, lumbago, general pain; Normal or the mile abnormality of laboratory indexes; Do not reach some rheumatismal diagnostic criteria, when Western medicine selects treatment to have any problem, can select treatment by Chinese herbs; Can effectively improve patient's clinical symptoms, alleviate less patient suffering.The chronic rheumatism of having made a definite diagnosis such as rheumatoid arthritis, ankylosing spondylitis etc.; Can take to control with the Chinese herb decoction opinion according to the state of an illness be master's Therapeutic Principle, adopts different treatment methods such as dispelling wind damp eliminating, dispelling cold by warming the meridian, the cold damp eliminating of temperature, clearing away heat and cooling blood, promoting blood circulation to remove obstruction in the collateral, invigorating the kidney and strengthening the bones respectively.Or dispersing wind and cold in outside, or removing damp-heat is in interior, or invigorates blood circulation with blood stasis dispelling, or warming the meridian is with collateral dredging, heresy is removed ruton, " general rule is not bitterly " is so can alleviate the patient suffering rapidly.Research shows that clinical expelling wind and removing dampness class Chinese medicine commonly used has the anti-inflammatory and analgesic effect same with the Western medicine nonsteroidal anti-inflammatory analgetic mostly, though its power that alleviates patient's clinical symptoms is slightly poorer than Western medicine, side effect seldom clinically combines dialectical taking the circumstances into consideration to select for use.
3. the Western medicine deficiency be can remedy, and its toxic and side effects dispelling cold by warming the meridian, expelling wind and activating blood circulation, removing obstruction in the collateral to relieve pain alleviated.
Throughout the year, be the optimum season of rheumatoid arthritis patients treatment and rehabilitation summer.The patient should add to note aspect following in summer.Adhering to treating conventional therapy outward also should be under physician guidance, uses the Chinese medicine with spleen invigorating, removing dampness, collateral dredging effect, like decoction of four noble drugs, SIWU TANG, LIUWEI DIHUANG WAN, shenfu decoction etc., to improve arthralgia, swelling, symptom such as stiff.Simultaneously, can dispel damp, benefiting QI and nourishing blood obviously strengthens patient's reticuloendothelial system phagocytic function, promotes lymphocyte transformation and forms active garland.
Claims (1)
1. treat rheumatismal Chinese medicine preparation for one kind, the component of this prescription is:
Windproof 25～30g; Rhizoma Et Radix Notopterygii 25～30g; The Radix Angelicae Dahuricae 12～15g; Herba Asari 8～10g; Radix Puerariae 20～30g; Periostracum Cicadae 12～15g; Herba Menthae 10～15g; Radix Angelicae Pubescentis 20～30g; Radix Aconiti Preparata 8～10g; 1～2 of Agkistrodon; Lignum Pini Nodi 15～20g; Ramulus Mori 15～20g; Rhizoma Dioscoreae Nipponicae 10～15g; Rhizoma Cibotii 15～20g; Rhizoma Homalomenae 15～20g; Cortex Magnoliae Officinalis 15～20g; Fructus Amomi 8～10g; Fructus Aurantii Immaturus 15～20g; The Radix Linderae 15～20g; Pericarpium Citri Reticulatae 20～30g; Radix Cirsii Japonici 15～20g; Radix Notoginseng 15～20g; Myrrha 15～20g; Radix Curcumae 15～20g; Oletum Trogopterori 10～15g; Flos Carthami 20～30g; Semen Persicae 20～30g; Radix Salviae Miltiorrhizae 25～30g; Rhizoma Drynariae 15～20g; Sanguis Draxonis 15～20g; Hirudo 10～15g; Ramulus Uncariae Cum Uncis 15～20g; Rhizoma Gastrodiae 15～20g; Pheretima 10～15g; Scorpio 10～15g; 2～3 of Scolopendras; The bar Radix Astragali 15～20g; Radix Codonopsis 10～15g; Rhizoma Curculiginis 12～15g; The Cortex Eucommiae 15～20g; Radix Angelicae Sinensis 20～30g; Radix Rehmanniae Preparata 15～20g; Radix Glycyrrhizae 15～20g; Radix Asparagi 15～20g; Rhizoma Polygonati Odorati 15～20g; Fructus Ligustri Lucidi 10～15g; Herba Ecliptae 15～20g.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011103211871A CN102366602A (en) | 2011-10-21 | 2011-10-21 | Traditional Chinese medicine formula used for treating rheumatism |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011103211871A CN102366602A (en) | 2011-10-21 | 2011-10-21 | Traditional Chinese medicine formula used for treating rheumatism |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102366602A true CN102366602A (en) | 2012-03-07 |
Family
ID=45759222
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2011103211871A Pending CN102366602A (en) | 2011-10-21 | 2011-10-21 | Traditional Chinese medicine formula used for treating rheumatism |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102366602A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103191383A (en) * | 2013-03-14 | 2013-07-10 | 黄相杰 | Traditional Chinese medicine composition for treating rheumatoid arthritis |
| CN103330806A (en) * | 2013-07-04 | 2013-10-02 | 虞攀峰 | Drug for treatment of rheumatoid arthritis |
| CN105477519A (en) * | 2015-12-22 | 2016-04-13 | 王凯 | Rheumatism arthralgia treating traditional Chinese medicine |
-
2011
- 2011-10-21 CN CN2011103211871A patent/CN102366602A/en active Pending
Non-Patent Citations (1)
| Title |
|---|
| 方勇飞等: "风湿病中成药数据库的建立及处方分析", 《第五届中西医结合风湿学术会议论文汇编》 * |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103191383A (en) * | 2013-03-14 | 2013-07-10 | 黄相杰 | Traditional Chinese medicine composition for treating rheumatoid arthritis |
| CN103191383B (en) * | 2013-03-14 | 2014-07-23 | 黄相杰 | Traditional Chinese medicine composition for treating rheumatoid arthritis |
| CN103330806A (en) * | 2013-07-04 | 2013-10-02 | 虞攀峰 | Drug for treatment of rheumatoid arthritis |
| CN105477519A (en) * | 2015-12-22 | 2016-04-13 | 王凯 | Rheumatism arthralgia treating traditional Chinese medicine |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101485836A (en) | Oral capsule for treating neck, waist and leg pain diseases and preparation method thereof | |
| CN103349753B (en) | Traditional Chinese medicine composition for treating kidney deficiency | |
| CN102512630B (en) | Traditional Chinese medicine composition for treating gallbladder calculus | |
| CN103341079B (en) | Chinese medicine composition for treating acne | |
| CN104013910A (en) | Traditional Chinese medicine composition for treating hypertension | |
| CN103041200B (en) | Traditional Chinese medicine composition for treating cerebral hemorrhage | |
| CN102366602A (en) | Traditional Chinese medicine formula used for treating rheumatism | |
| CN104000933A (en) | Traditional Chinese medicine oral liquid for treating osteoproliferation | |
| CN103041301B (en) | Traditional Chinese medicine composition for treating icterohepatitis | |
| CN103223139B (en) | Traditional Chinese medicinal composition for treating chronic ulcerative colitis | |
| CN105641128A (en) | Traditional Chinese medicine composition for treating herpes zoster | |
| CN105770294A (en) | Traditional Chinese medicine composition for treating hysteromyoma | |
| CN103272129B (en) | Traditional Chinese medicine composition for treating neurodermatitis | |
| CN104825916A (en) | Traditional Chinese medicine composition for treating rheumatoid arthritis and preparation method thereof | |
| CN102416150B (en) | Chinese medicinal composition for treating diarrhoea | |
| CN105663612A (en) | Traditional Chinese medicine composition for treating ankylosing spondylitis | |
| CN105920292A (en) | Chinese medicinal composition for treating acute mastitis | |
| CN105250956A (en) | Chinese herb composition for treating colitis | |
| CN104771488A (en) | Traditional Chinese medicine composition for treating rheumatic arthritis | |
| CN104873897A (en) | Traditional Chinese medicine composition for treating acute lumbar muscle sprain | |
| CN105617214A (en) | Traditional Chinese medicine composition for treating scabies | |
| CN104758851A (en) | Traditional Chinese medicine composition for treating stroke sequela | |
| CN104013785A (en) | Traditional Chinese medicine oral solution for treating rheumatism | |
| CN104688916A (en) | TCM (Traditional Chinese Medicine) composition for treating psoriasis | |
| CN104173930A (en) | Traditional Chinese medicine composition for treating cold-damp lumbago |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20120307 |